Status:
COMPLETED
Intra-articular Doxycycline: A Novel Treatment of Adhesive Capsulitis
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
Orthopedic Research and Education Foundation
Conditions:
Adhesive Capsulitis
Adhesive Capsulitis of Unspecified Shoulder
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
We will recruit a total of 40 patients from the Vanderbilt Sports Medicine Clinics who have been diagnosed with adhesive capsulitis and have not undergone any previous treatment. The 40 patients will ...
Detailed Description
Adhesive capsulitis, also known as frozen shoulder, is a common condition of the shoulder joint affecting 2-5% of the adult population and characterized by progressive, painful loss of both passive an...
Eligibility Criteria
Inclusion
- 18 years of age and older,
- diagnosis of stage II adhesive capsulitis as determined by clinical examination of the treating physician, and
- absence of abnormal findings on X-ray.
Exclusion
- allergy to Doxycycline or Methylprednisolone,
- pregnancy,
- diagnosis,
- Inflammatory arthritis or diabetes,
- secondary adhesive capsulitis (history of significant trauma, rotator cuff tear injury, stroke)
- evidence of arthritis on x-ray,
- current infectious disease, and
- any previous treatment for the for adhesive capsulitis of the affected shoulder.
Key Trial Info
Start Date :
March 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 8 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03479502
Start Date
March 5 2018
End Date
February 8 2022
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt Medical Center
Nashville, Tennessee, United States, 37232